Department of Paediatrics, University of Otago, Christchurch, New Zealand.
Department of Paediatric Gastroenterology, Sydney Children's Hospital, Australia.
J Pediatr Gastroenterol Nutr. 2019 Jul;69(1):e7-e12. doi: 10.1097/MPG.0000000000002329.
Clinical symptom evaluation for children with inflammatory bowel disease (IBD) is typically done using composite tools: the Pediatric Crohn's Disease Activity Index (PCDAI) and Pediatric Ulcerative Colitis Activity Index (PUCAI). Both rely on clinician interpretation of child or parent symptom recall. No universal self-report tool has yet been developed for children with IBD to assess and report their symptoms. The research objective was to develop a self-report tool that produced information congruent with that obtained by clinicians using the PUCAI or PCDAI.
A children's symptom self-report tool (IBDnow) was developed with picture and text Likert symptom scales. The clinician and child completed their reports during the same outpatient consultation. Agreement levels were calculated at the individual level (identical child and clinician answers), category level (symptom severity), and aggregate level (cohort scores). Internal consistency was measured with Cronbach alpha.
One hundred children from Christchurch (New Zealand) (n = 65), and Sydney (Australia) (n = 35) completed the study (Crohn's Disease (CD):88, ulcerative colitis (UC):12), mean age 13.9 years (±3.6). Mean individual agreement was 0.76 (±0.19). Category severity had very good or good inter-rater reliability for 5 of the 7 symptom scales and overall severity agreement of 76%. Aggregate mean scores were significantly different between clinicians (14.9, ±18.8), and participants (21.6, ±19.4), (P <0.005, confidence interval -9.0, -4.4), but 60 pairs had scores within a 10% margin. Cronbach alpha was 0.74.
This self-report tool had good proportionate agreement between raters, and good crude agreement for symptom categories. Assigning PUCAI or PCDAI scores caused inter-rater discrepancies to be misleadingly magnified. Pediatric gastroenterologists may consider utilizing IBDnow to elicit symptom self-reports from children with IBD to enable them to communicate meaningful information on their ongoing symptom burden. This would be a positive step in helping children feel included in clinical encounters and promoting self-management, at the same time producing valid, subjective symptom recall.
对炎症性肠病(IBD)患儿的临床症状评估通常采用综合工具进行:小儿克罗恩病活动指数(PCDAI)和小儿溃疡性结肠炎活动指数(PUCAI)。这两种工具都依赖于临床医生对儿童或家长症状回忆的解释。目前还没有为 IBD 患儿开发出通用的自我报告工具来评估和报告他们的症状。本研究旨在开发一种自我报告工具,该工具产生的信息与使用 PUCAI 或 PCDAI 获得的临床医生信息一致。
使用图片和文字 Likert 症状量表开发了儿童症状自我报告工具(IBDnow)。临床医生和儿童在同一次门诊就诊时完成报告。在个体水平(儿童和临床医生的回答相同)、类别水平(症状严重程度)和综合水平(队列评分)上计算了一致性水平。使用 Cronbach alpha 测量内部一致性。
来自基督城(新西兰)(n=65)和悉尼(澳大利亚)(n=35)的 100 名儿童完成了这项研究(克罗恩病(CD):88 例,溃疡性结肠炎(UC):12 例),平均年龄 13.9 岁(±3.6)。平均个体一致性为 0.76(±0.19)。7 个症状量表中有 5 个症状严重程度的类别具有很好或良好的评分者间可靠性,整体严重程度的一致性为 76%。临床医生(14.9,±18.8)和参与者(21.6,±19.4)的平均综合评分差异显著(P<0.005,置信区间-9.0,-4.4),但 60 对评分的差异在 10%以内。Cronbach alpha 为 0.74。
该自我报告工具在评分者之间具有良好的比例一致性,对于症状类别具有良好的粗略一致性。分配 PUCAI 或 PCDAI 评分会导致评分者之间的差异被夸大。儿科胃肠病学家可能会考虑使用 IBDnow 从 IBD 患儿那里获取症状自我报告,使他们能够就其持续的症状负担提供有意义的信息。这将是帮助患儿感到被纳入临床诊疗过程并促进自我管理的积极步骤,同时也能提供有效的主观症状回忆。